Narrow search
Showing 1 - 10 of 2,383
Cover Image
Regulation of pharmaceutical prices : evidence from a reference price reform in Denmark
Kaiser, Ulrich; Méndez, Susan J.; Rønde, Thomas; … - In: Journal of health economics 36 (2014), pp. 174-187
Persistent link: https://www.econbiz.de/10010483181
Cover Image
How Do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs
Nguyen, Thuy Dieu - 2019
Prior work considers effects of prescribing restrictions on opioid use but not upstream implications for pharmaceutical marketing activities, despite the inordinate role many believe marketing played in the crisis. Our study proposes a stylized model of pharmaceutical payments and investigates...
Persistent link: https://www.econbiz.de/10012861727
Cover Image
Price Cap Regulation in the Colombian Pharmaceutical Market : An Impact Evaluation
Bardey, David; Harker, Arturo; Zuluaga, Daniela - 2021
We evaluate the impact of a price cap regulation implemented in the Colombian pharmaceutical market between 2011 and … after regulation) for the eighteen ATC groups. A triple differences model with fixed time effects and cluster errors is used … to identify the impact of this regulation. We find that the price-cap regulation contributed to reduce prices in three of …
Persistent link: https://www.econbiz.de/10013238087
Cover Image
How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs
Nguyen, Thuy D. - 2019
Prior work considers effects of prescribing restrictions on opioid use but not upstream implications for pharmaceutical marketing activities, despite the inordinate role many believe marketing played in the crisis. Our study proposes a stylized model of pharmaceutical payments and investigates...
Persistent link: https://www.econbiz.de/10012480300
Cover Image
Price cap regulation in the Colombian pharmaceutical market: an impact evaluation
Bardey, David; Harker, Arturo; Zuluaga, Daniela - 2021
Persistent link: https://www.econbiz.de/10012598467
Cover Image
Price cap regulation in the Colombian pharmaceutical market : an impact evaluation
Bardey, David; Harker, Arturo; Zuluaga, Daniela - 2021
Persistent link: https://www.econbiz.de/10012488757
Cover Image
Unpacking the effects of adverse regulatory events : Evidence from pharmaceutical relabeling
Higgins, Matthew J.; Yan, Xin; Chatterjee, Chirantan - In: Research policy : policy, management and economic … 50 (2021) 1, pp. 1-15
Persistent link: https://www.econbiz.de/10012663313
Cover Image
What drives innovation? : lessons from COVID-19 R&D
Agarwal, Ruchir; Gaulé, Patrick - 2021
To examine the drivers of innovation, this paper studies the global R and D effort to fight the deadliest diseases and presents four results. We find: (1) global pharmaceutical R and D activity-measured by clinical trials-typically follows the 'law of diminishing effort': id est the elasticity...
Persistent link: https://www.econbiz.de/10012518690
Cover Image
Does the crowd-out effect of R&D subsidies exist in the pharmaceutical industry? : evidence from Chinese companies
Ni, Kejin - In: Modern economy 11 (2020) 3, pp. 645-656
Persistent link: https://www.econbiz.de/10012501487
Cover Image
What drives innovation? : lessons from COVID-19 R&D
Agarwal, Ruchir; Gaulé, Patrick - 2021
To examine the drivers of innovation, this paper studies the global R&D effort to fight the deadliest diseases and presents four results. We find: (1) global pharmaceutical R&D activity - measured by clinical trials - typically follows the 'law of diminishing efforts': i.e. the elasticity of R&D...
Persistent link: https://www.econbiz.de/10012430944